2m 2m 2m 2m 2m 2m 2m
Arbutus Biopharm (ABUS)
NASDAQ
$4.20+$0.02 (+0.48%)
Price as of Oct 22, 2026 7:42 PM EDT- $640.7MMarket Cap
- -5.64%1-Year Change
- BiotechnologyIndustry
Arbutus Biopharm (ABUS)
$4.20+$0.02 (+0.48%)
Earnings Score
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 10.84% | ||
12-Month Momentum | 11.83% | ||
3-Month Risk Adjusted Momentum | 72.81% | ||
12-Month Risk Adjusted Momentum | 27.14% |
True Yield
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 28 |